Allan Brown
Chief Executive Officer at Glycoscoredx Ltd.
Allan Brown active positions
| Companies | Position | Start | End |
|---|---|---|---|
Glycoscoredx Ltd.
 Glycoscoredx Ltd. Miscellaneous Commercial ServicesCommercial Services Glycoscoredx Ltd. develops a novel blood test that revolutionizes how prostate cancer is diagnosed. The company is based in Newcastle upon Tyne, UK. The British company was founded in 2020 by Jennifer Munkley. Allan Brown has been the CEO of the company since 2020. | Chief Executive Officer | 2020-08-31 | - |
Career history of Allan Brown
Former positions of Allan Brown
| Companies | Position | Start | End |
|---|---|---|---|
| GENEDRIVE PLC | Director/Board Member | 2014-01-31 | 2017-11-07 |
| Chief Operating Officer | 2014-01-31 | 2017-11-07 | |
Hologic Ltd.
 Hologic Ltd. Medical SpecialtiesHealth Technology Hologic Ltd. manufactures life sciences products and services with two divisions, Molecular Diagnostics and Research Products & Services. The firm has laboratories, manufacturing and operations in the USA, UK and France. It provides test kits, reagents and services to two synergistic markets. It focuses on these niche opportunities with products, patents, expertise and acquisitions. The company was founded in 1992 and is headquartered in Wythenshawe, the United Kingdom. | Corporate Officer/Principal | - | 2009-12-31 |
Statistics
International
| United Kingdom | 4 |
Operational
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| GENEDRIVE PLC | Health Technology |
| Private companies | 2 |
|---|---|
Hologic Ltd.
Hologic Ltd. Medical SpecialtiesHealth Technology Hologic Ltd. manufactures life sciences products and services with two divisions, Molecular Diagnostics and Research Products & Services. The firm has laboratories, manufacturing and operations in the USA, UK and France. It provides test kits, reagents and services to two synergistic markets. It focuses on these niche opportunities with products, patents, expertise and acquisitions. The company was founded in 1992 and is headquartered in Wythenshawe, the United Kingdom. | Health Technology |
Glycoscoredx Ltd.
Glycoscoredx Ltd. Miscellaneous Commercial ServicesCommercial Services Glycoscoredx Ltd. develops a novel blood test that revolutionizes how prostate cancer is diagnosed. The company is based in Newcastle upon Tyne, UK. The British company was founded in 2020 by Jennifer Munkley. Allan Brown has been the CEO of the company since 2020. | Commercial Services |
- Stock Market
- Insiders
- Allan Brown
- Experience
